Endeavor Pharmaceuticals
Endeavor Pharmaceuticals producer of hormone replacement therapy pharmaceuticals.
Market cap
-
Enterprise valuation
€32m (Public information from Dec 2003)
Wilmington Delaware (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$46.0m | Series E | ||
$35.0m Valuation: $35.0m | Acquisition | ||
| Total Funding | €41.8m | ||